Alice Natalucci -

Pharmaceutical companies frequently cooperate with patient associations by involving their representatives as speakers in events and meetings.

Relationships between pharmaceutical companies and patient associations are strictly regulated and no promotional purpose is allowed.

Farmindustria Code of Conduct provides guidelines and criteria companies should comply with when collaborating with patient associations.

With the latest version of the Code, released on 5th April 2022, Farmindustria has introduced the “Expert Patient”.

Patients are considered “Expert Patients” if, beyond having a direct experience and knowledge of the disease, have specific skills related to research, regulatory and advocacy activities – certifications and certificates might be made available.

The collaboration should comply with several criteria and Farmindustria provides a guideline for hospitality, fees for service, transparency rules etc.

Regulatory Pharma Net is available to provide your company with any updates and to support on all regulatory needs on this topic.

Do not hesitate to contact us at

Comments are closed for this post.